Anti-Diabetic API Supplier for Philippines — WHO GMP Certified

Aarise Pharmaceuticals exports WHO GMP certified anti-diabetic APIs to Philippines (FDA Philippines). We are a Haridwar, India-based API manufacturer supplying anti-diabetic active pharmaceutical ingredients used in the formulation of oral hypoglycaemic agents, insulin sensitisers, and DPP-4 inhibitors to pharmaceutical buyers in Philippines — Southeast Asia’s second-largest pharmaceutical market.

Exporting Anti-Diabetic APIs to Philippines

Philippine FDA registration required; WHO GMP certificate accepted for API imports. Aarise Pharmaceuticals provides all required documentation — COA, MSDS, WHO GMP Certificate, COPP, DMF dossier, and Certificate of Origin — to facilitate smooth regulatory clearance for FDA Philippines requirements.

Molecules Available for Export to Philippines

We supply the following anti-diabetic APIs to Philippines: Metformin HCl, Glimepiride, Sitagliptin, Glibenclamide, Voglibose. All molecules available in USP, BP, and IP grades at 98–99%+ purity. Additional molecules available on request.

Why Philippines Buyers Choose Aarise

• WHO GMP Certified — recognised by FDA Philippines for bulk API imports
• FDA Philippines-Ready Documentation — full regulatory dossier provided with every shipment
• NABL-Accredited QC — in-house analytical testing to pharmacopeial standards
• Competitive Pricing — direct manufacturer pricing, no middlemen
• Reliable Lead Times — 5–10 days standard; air freight available for urgent orders
• Dedicated Export Team — experienced in Philippines import compliance and logistics

Regulatory Documentation for Philippines

• Certificate of Analysis (COA) — batch-specific, signed by QC head
• WHO GMP Certificate — current, accepted by FDA Philippines
• MSDS / SDS in GHS format
• Certificate of Pharmaceutical Product (COPP)
• DMF filing support for FDA Philippines
• Certificate of Origin (for customs clearance in Philippines)

Shipping to Philippines

We ship anti-diabetic APIs to Philippines via air freight (DHL, FedEx, UPS) and sea freight for large volume orders. Standard transit time: 3–7 days by air, 18–25 days by sea. We handle all export documentation including commercial invoice, packing list, COO, and pharma-grade shipping declarations.

Request a Quote for Philippines

To receive pricing, samples, or a regulatory documentation pack for anti-diabetic API supply to Philippines, contact Aarise Pharmaceuticals at +91 9899783330. We respond within 24 hours.

Frequently Asked Questions

Can Aarise export anti-diabetic APIs directly to Philippines?

Yes. Aarise Pharmaceuticals has active export experience to Philippines and can supply anti-diabetic APIs with complete FDA Philippines-compliant documentation including COA, WHO GMP certificate, and DMF support.

What documentation is required to import anti-diabetic APIs into Philippines?

Philippine FDA registration required; WHO GMP certificate accepted for API imports. Aarise provides all required documents — COA, WHO GMP Certificate, COPP, MSDS, and Certificate of Origin — to support your import clearance.

What anti-diabetic molecules are available for export to Philippines?

We supply Metformin HCl, Glimepiride, Sitagliptin, Glibenclamide, Voglibose for export to Philippines. All molecules are available in USP/BP/IP pharmacopeial grade. Additional molecules available on request.

How long does delivery take from India to Philippines?

Air freight takes 3–7 business days from Haridwar to Philippines. Sea freight for large volumes takes 18–25 days. We dispatch samples within 3–5 business days of order confirmation.

Is there a minimum order for Philippines export?

MOQ starts from 100g for most anti-diabetic APIs. Samples from 10–50g are available for development and regulatory filing. Contact us for volume pricing for commercial quantities.